SEATTLE, WA -- (Marketwire) -- 06/28/11 -- Pacific Biomarkers, Inc. (PBI) (OTCBB: PBMC), a provider of biomarker laboratory services to the pharmaceutical, biotechnology and diagnostics industries, is pleased to announce that Amar A. Sethi, MD, PhD, the Company's Vice President of Research and Development, has been named one ... read more

SEATTLE, WA -- (Marketwire) -- 06/09/11 -- Amar A. Sethi, MD, PhD, Vice President of Research and Development at Pacific Biomarkers, Inc. (PBI) (OTCBB: PBMC), a provider of biomarker laboratory services to the pharmaceutical, biotechnology and diagnostics industries, today offered remarks on a National Institutes of Health study ... read more

SEATTLE, WA -- (Marketwire) -- 05/26/11 -- Two senior researchers at Pacific Biomarkers, Inc. (PBI) (OTCBB: PBMC), a provider of biomarker laboratory services to the pharmaceutical, biotechnology and diagnostics industries, have an article featured in the May/June 2011 issue of IVD Technology magazine. Timothy H. Carlson, PhD, Laboratory ... read more

SEATTLE, WA -- (Marketwire) -- 05/16/11 -- Pacific Biomarkers, Inc. (OTCBB: PBMC) ("PBI"), a leading provider of biomarker laboratory services and contract research services, today announced its operating results for the third quarter and first nine months of FY2011. For the three months ended March 31, 2011 (the third ... read more

SEATTLE, WA -- (Marketwire) -- 05/12/11 -- Pacific Biomarkers, Inc. (PBI) (OTCBB: PBMC), a provider of biomarker laboratory services to the pharmaceutical, biotechnology and diagnostics industries, announced that representatives from the company will speak at the 2011 AAPS National Biotechnology Conference being held at the Hilton San Francisco ... read more

SEATTLE, WA -- (Marketwire) -- 04/26/11 -- Pacific Biomarkers, Inc. (PBI) (OTCBB: PBMC), a provider of biomarker laboratory services to the pharmaceutical, biotechnology and diagnostics industries, has been awarded by one sponsor, nine contracts in early 2011 with a total value of approximately $920,000. The nine contracts are ... read more

SEATTLE, WA -- (Marketwire) -- 03/22/11 -- Pacific Biomarkers, Inc. (PBI) (OTCBB: PBMC), a provider of biomarker laboratory services to the pharmaceutical, biotechnology and diagnostics industries, will be exhibiting at the 20th Annual Partnerships in Clinical Trials Conference to be held at the Phoenix Convention Center in Phoenix, ... read more

SEATTLE, WA -- (Marketwire) -- 03/01/11 -- Pacific Biomarkers, Inc. (PBI) (OTCBB: PBMC), a provider of biomarker laboratory services to the pharmaceutical, biotechnology and diagnostics industries, is pleased to announce that Amar A. Sethi, MD, PhD, the Company's Vice President of Research and Development, has been named as ... read more

SEATTLE, WA -- (Marketwire) -- 02/17/11 -- Pacific Biomarkers, Inc. (PBI) (OTCBB: PBMC), a provider of biomarker laboratory services to the pharmaceutical, biotechnology and diagnostics industries, will host a webinar titled "Biomarkers of Metabolic Syndrome in Clinical Trials" on Wednesday, March 2 at 11:00 am PST. During the webinar, ... read more

SEATTLE, WA -- (Marketwire) -- 02/15/11 -- Pacific Biomarkers, Inc. (OTCBB: PBMC), a leading provider of specialized biomarker and contract research services, today announced its operating results for the second quarter and first half of FY2011. For the three months ended December 31, 2010 (the second quarter of FY2011), revenue increased 20% to $2,532,069, ... read more

SEATTLE, WA -- (Marketwire) -- 01/31/11 -- Pacific Biomarkers, Inc. (PBI) (OTCBB: PBMC), a provider of biomarker laboratory services to the pharmaceutical, biotechnology and diagnostics industries, has promoted Sheri' DuMond to Director of Business Development following her role as Senior Associate Director of Business Development at PBI. In her new ... read more

SEATTLE, WA -- (Marketwire) -- 01/11/11 -- Pacific Biomarkers, Inc. (OTCBB: PBMC) ("PBI"), a provider of biomarker laboratory services to the pharmaceutical, biotechnology and diagnostics industries, announced today that it has been awarded two major research contracts with two multinational pharmaceutical companies (the "Sponsors") to provide clinical biomarker services. ... read more

SEATTLE, WA -- (Marketwire) -- 01/06/11 -- Pacific Biomarkers, Inc. (OTCBB: PBMC), a provider of biomarker laboratory services to the pharmaceutical, biotechnology and diagnostics industries, announced that it has noted, with great interest, the publication of new studies suggesting that a simple urine test could help prevent cases ... read more

SEATTLE, WA -- (Marketwire) -- 01/05/11 -- Pacific Biomarkers, Inc. (PBI) (OTCBB: PBMC), a provider of biomarker laboratory services to the pharmaceutical, biotechnology and diagnostics industries, today announced the establishment of a Scientific Advisory Board. The Scientific Advisory Board (SAB) was created by, and reports to, the Company's Science ... read more

SEATTLE, WA -- (Marketwire) -- 11/22/10 -- Pacific Biomarkers, Inc. (OTCBB: PBMC), a provider of biomarker laboratory services to the pharmaceutical, biotechnology and diagnostics industries, today announced that it has noted, with great interest, a study on the experimental cholesterol drug Anacetrapib and its ability to boost good ... read more

SEATTLE, WA -- (Marketwire) -- 10/27/10 -- Pacific Biomarkers, Inc. (OTCBB: PBMC), a provider of biomarker laboratory services to the pharmaceutical, biotechnology and diagnostics industries, today announced that it is one of the companies on Technology Fast 500™, Deloitte's ranking of 500 of the fastest growing technology, media, ... read more

SEATTLE, WA -- (Marketwire) -- 07/28/10 -- Pacific Biomarkers, Inc. (OTCBB: PBMC), a provider of biomarker laboratory services to the pharmaceutical, biotechnology and diagnostics industries, unveiled its new website on Friday, July 23. The site, www.PacBio.com, incorporates numerous features to make browsing a more fruitful experience for the Company's ... read more